Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | E194K | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | E94K | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | H45D | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | Q116* | Nonsense | 1 |
| BLCA | Bladder urothelial carcinoma | T316S | Missense | 1 |
| BRCA | Breast invasive carcinoma | A118G | Missense | 1 |
| BRCA | Breast invasive carcinoma | E184K | Missense | 1 |
| BRCA | Breast invasive carcinoma | S138C | Missense | 1 |
| BRCA | Breast invasive carcinoma | T149T | Silent | 1 |
| CESC | Cervical and endocervical cancers | A286T | Missense | 1 |
| CESC | Cervical and endocervical cancers | G298R | Missense | 1 |
| CESC | Cervical and endocervical cancers | P3P | Silent | 1 |
| CESC | Cervical and endocervical cancers | R308Q | Missense | 1 |
| COAD | Colon adenocarcinoma | F11F | Silent | 1 |
| COAD | Colon adenocarcinoma | K151N | Missense | 1 |
| COAD | Colon adenocarcinoma | L233I | Missense | 1 |
| COAD | Colon adenocarcinoma | P205L | Missense | 1 |
| COAD | Colon adenocarcinoma | T215A | Missense | 1 |
| ESCA | Esophageal carcinoma | A131S | Missense | 1 |
| GBM | Glioblastoma multiforme | R176G | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | I44V | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | Q170* | Nonsense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | Q280Q | Silent | 1 |
| KIRC | Kidney renal clear cell carcinoma | L326V | Missense | 1 |
| KIRP | Kidney renal papillary cell carcinoma | Y222H | Missense | 1 |
| LUAD | Lung adenocarcinoma | A252A | Silent | 1 |
| LUAD | Lung adenocarcinoma | E184* | Nonsense | 1 |
| LUAD | Lung adenocarcinoma | I260M | Missense | 1 |
| LUAD | Lung adenocarcinoma | M267V | Missense | 1 |
| LUAD | Lung adenocarcinoma | R173W | Missense | 1 |
| LUAD | Lung adenocarcinoma | R308Q | Missense | 1 |
| LUAD | Lung adenocarcinoma | R359G | Missense | 1 |
| LUAD | Lung adenocarcinoma | R56M | Missense | 1 |
| PAAD | Pancreatic adenocarcinoma | A252V | Missense | 1 |
| PRAD | Prostate adenocarcinoma | L73P | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | L220L | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | S294F | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | V266A | Missense | 1 |
| STAD | Stomach adenocarcinoma | D349N | Missense | 1 |
| STAD | Stomach adenocarcinoma | G298G | Silent | 1 |
| STAD | Stomach adenocarcinoma | K51T | Missense | 1 |
| STAD | Stomach adenocarcinoma | R16* | Nonsense | 1 |
| STAD | Stomach adenocarcinoma | V101E | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A299V | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A54V | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | L268L | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R16* | Nonsense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 0 | 11.8 | 20 |
| BRCA | Breast invasive carcinoma | 976 | 12.5 | 8.8 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 12.5 | 8.8 | 0 |
| COAD | Colon adenocarcinoma | 367 | 12.5 | 11.8 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 2.9 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 2.9 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 12.5 | 2.9 | 20 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 2.9 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 2.9 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 0 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 0 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 12.5 | 17.6 | 20 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 0 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 2.9 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 2.9 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 12.5 | 5.9 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 12.5 | 8.8 | 20 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 12.5 | 5.9 | 20 |